Recursion Pharmaceuticals (RXRX) PT Lowered to $12 at KeyBanc

July 11, 2024 3:20 AM EDT Send to a Friend

KeyBanc analyst Scott Schoenhaus lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Recursion Pharmaceuticals (RXRX) PT Lowered to $12 at KeyBanc

Member Login

Free News Feed